Co-diagnostics (CODX) news
Recent news
Co-Diagnostics and ReadyGo collaborate to evaluate blood-based molecular testing at the point of need, starting with Ebola
AInvest Wire · Sep 16, 2026Co-Diagnostics - Enters material transfer agreement with ReadyGo Diagnostics in August 2026 - SEC filing
Co-Diagnostics, Inc. has entered into a material transfer agreement with ReadyGo Diagnostics in August 2026, as disclosed in a recent SEC filing. The agreement outlines the terms under which materials will be transferred between the two entities, though specific details regarding the scope,…
AInvest Wire · Sep 15, 2026Co-Diagnostics - ReadyGo to provide sampling materials to co-diagnostics for feasibility studies - SEC filing
AInvest Wire · Sep 15, 2026Co-Diagnostics - Appoints Daniel Bohrer as principal financial officer effective September 2, 2026 - SEC filing
AInvest Wire · Sep 4, 2026Co-Diagnostics - Brian Brown steps down as CFO effective September 2, 2026 - SEC filing
Co-Diagnostics, Inc. (NASDAQ: CODX) has announced that Brian Brown will step down as Chief Financial Officer effective September 2, 2026, according to a recent SEC filing . Brown has served in the role for several years and his departure marks a leadership transition within the finance department…
AInvest Wire · Sep 4, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.